☰

Arthur W. Lambert, Ph.D. - Publications

Affiliations: 
2013 Molecular and Translational Medicine Boston University, Boston, MA, United States 
Area:
Molecular Biology, Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Lambert AW, Fiore C, Chutake Y, Verhaar ER, Strasser PC, Chen MW, Farouq D, Das S, Li X, Eaton EN, Zhang Y, Liu Donaher J, Engstrom I, Reinhardt F, Yuan B, et al. ΔNp63/p73 drive metastatic colonization by controlling a regenerative epithelial stem cell program in quasi-mesenchymal cancer stem cells. Developmental Cell. 57: 2714-2730.e8. PMID 36538894 DOI: 10.1016/j.devcel.2022.11.015  0.403
2022 Zhang Y, Donaher JL, Das S, Li X, Reinhardt F, Krall JA, Lambert AW, Thiru P, Keys HR, Khan M, Hofree M, Wilson MM, Yedier-Bayram O, Lack NA, Onder TT, et al. Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis. Nature Cell Biology. PMID 35411083 DOI: 10.1038/s41556-022-00877-0  0.321
2021 Lambert AW, Weinberg RA. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nature Reviews. Cancer. PMID 33547455 DOI: 10.1038/s41568-021-00332-6  0.367
2020 Wong CK, Lambert AW, Ozturk S, Papageorgis P, Lopez D, Shen N, Sen Z, Abdolmaleky HM, Győrffy B, Feng H, Thiagalingam S. Targeting RICTOR sensitizes SMAD4-negative colon cancer to irinotecan. Molecular Cancer Research : McR. PMID 31932471 DOI: 10.1158/1541-7786.Mcr-19-0525  0.518
2020 Lambert A, Fiore C, Chutake Y, Verhaar E, Chen MW, Donaher J, Reinhardt F, Engstrom I, Yuan B, Bierie B, Farouq D, Carulli J, Olson E, Guenther M, Weinberg R. Abstract P4-04-02: Epigenomic analysis of cancer stem cells (CSCs) from triple-negative breast cancer (TNBC) reveals p63 and p73 as core metastasis drivers Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-04-02  0.573
2018 Krall JA, Reinhardt F, Mercury OA, Pattabiraman DR, Brooks MW, Dougan M, Lambert AW, Bierie B, Ploegh HL, Dougan SK, Weinberg RA. The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy. Science Translational Medicine. 10. PMID 29643230 DOI: 10.1126/Scitranslmed.Aan3464  0.406
2018 Guenther M, Lambert A, Chen M, Fiore C, Eaton M, Orlando D, Bierie B, Weinberg R, Fritz C, Olson E. Abstract P2-04-03: Epigenomic analysis of cancer stem cell (CSC)-enriched triple-negative breast cancer (TNBC) populations reveals gene regulatory circuitry and novel tumor cell vulnerabilities Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P2-04-03  0.582
2017 Lambert AW, Pattabiraman DR, Weinberg RA. Emerging Biological Principles of Metastasis. Cell. 168: 670-691. PMID 28187288 DOI: 10.1016/J.Cell.2016.11.037  0.449
2016 Ozturk S, Papageorgis P, Wong CK, Lambert AW, Abdolmaleky HM, Thiagalingam A, Cohen HT, Thiagalingam S. SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 26739564 DOI: 10.1073/Pnas.1514663113  0.58
2015 Lambert AW, Wong CK, Ozturk S, Papageorgis P, Raghunathan R, Alekseyev Y, Gower AC, Reinhard BM, Abdolmaleky HM, Thiagalingam S. Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells. Molecular Cancer Research : McR. PMID 26507575 DOI: 10.1158/1541-7786.Mcr-15-0079  0.586
2015 Papageorgis P, Ozturk S, Lambert AW, Neophytou CM, Tzatsos A, Wong CK, Thiagalingam S, Constantinou AI. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis. Breast Cancer Research : Bcr. 17: 98. PMID 26208975 DOI: 10.1186/S13058-015-0607-Y  0.529
2015 Papageorgis P, Ozturk S, Lambert AW, Neophytou CM, Tzatsos A, Wong CK, Thiagalingam S, Constantinou AI. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis Breast Cancer Research. 17. DOI: 10.1186/s13058-015-0607-y  0.444
2013 Lambert AW, Ozturk S, Papageorgis P, Abdolmaleky H, Thiagalingam S. Abstract 4890: Periostin signaling regulates breast cancer stem cells. Cancer Research. 73: 4890-4890. DOI: 10.1158/1538-7445.Am2013-4890  0.617
2013 Lambert A, Ozturk S, Papageorgis P, Abdolmaleky H, Thiagalingam S. Abstract P1-06-13: Periostin controls cytokine production to maintain breast cancer stem cells Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P1-06-13  0.617
2012 Lambert AW, Ozturk S, Thiagalingam S. Integrin signaling in mammary epithelial cells and breast cancer. Isrn Oncology. 2012: 493283. PMID 22523705 DOI: 10.5402/2012/493283  0.538
2012 Lambert AW, Ozturk S, Thiagalingam S. Abstract 5191: Periostin signaling in breast cancer stem cells Cancer Research. 72: 5191-5191. DOI: 10.1158/1538-7445.Am2012-5191  0.563
2011 Papageorgis P, Cheng K, Ozturk S, Gong Y, Lambert AW, Abdolmaleky HM, Zhou JR, Thiagalingam S. Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Cancer Research. 71: 998-1008. PMID 21245094 DOI: 10.1158/0008-5472.Can-09-3269  0.53
2010 Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M, Thiagalingam S. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Research. 70: 968-78. PMID 20086175 DOI: 10.1158/0008-5472.Can-09-1872  0.522
2010 Thiagalingam S, Lambert AW, Ozturk S, Abdolmaleky HM, Papageorgis P. Abstract 187: Epigenetic memory during breast cancer progression is sustained by Smad signaling pathway Cancer Research. 70: 187-187. DOI: 10.1158/1538-7445.Am10-187  0.557
2009 Gao F, Ponte JF, Levy M, Papageorgis P, Cook NM, Ozturk S, Lambert AW, Thiagalingam A, Abdolmaleky HM, Sullivan BA, Thiagalingam S. hBub1 negatively regulates p53 mediated early cell death upon mitotic checkpoint activation. Cancer Biology & Therapy. 8: 548-56. PMID 19252416 DOI: 10.4161/Cbt.8.7.7929  0.394
2009 Gao F, Ponte JF, Papageorgis P, Levy M, Ozturk S, Lambert AW, Pan H, Chinnappan D, Cheng KH, Thiagalingam A, Abdolmaleky HM, Thiagalingam S. hBub1 deficiency triggers a novel p53 mediated early apoptotic checkpoint pathway in mitotic spindle damaged cells. Cancer Biology & Therapy. 8: 627-35. PMID 19242126 DOI: 10.4161/Cbt.8.7.7928  0.348
Show low-probability matches.